1833PDLack of efficiency of precision oncology with target-based investigational treatments for patients in early phase clinical trials based on pre-screened molecular alterations. - Spéville, B Doger de; Moreno, V; Hernandez, T; Boni, V; Miguel, M J de; Rojo, F; Lopez-Rios, F; Calvo, E (Annals of Oncology, 2018)